Target
Tyrosine-protein kinase Lck
Ligand
BDBM50077201
Substrate
n/a
Meas. Tech.
ChEMBL_221635 (CHEMBL823025)
Kd
15000±n/a nM
Citation
 Beaulieu, PLCameron, DRFerland, JMGauthier, JGhiro, EGillard, JGorys, VPoirier, MRancourt, JWernic, DLlinas-Brunet, MBetageri, RCardozo, MHickey, ERIngraham, RJakes, SKabcenell, AKirrane, TLukas, SPatel, UProudfoot, JSharma, RTong, LMoss, N Ligands for the tyrosine kinase p56lck SH2 domain: discovery of potent dipeptide derivatives with monocharged, nonhydrolyzable phosphate replacements. J Med Chem 42:1757-66 (1999) [PubMed]  Article 
Target
Name:
Tyrosine-protein kinase Lck
Synonyms:
2.7.10.2 | LCK | LCK_HUMAN | LSK | Leukocyte C-terminal Src kinase | Lymphocyte cell-specific protein-tyrosine kinase | Lymphocyte-specific protein tyrosine kinase | P56-LCK | Protein YT16 | Proto-oncogene Lck | Proto-oncogene tyrosine-protein kinase LCK | Src/Lck kinase | T cell-specific protein-tyrosine kinase
Type:
n/a
Mol. Mass.:
57987.83
Organism:
Homo sapiens (Human)
Description:
P06239
Residue:
509
Sequence:
MGCGCSSHPEDDWMENIDVCENCHYPIVPLDGKGTLLIRNGSEVRDPLVTYEGSNPPASPLQDNLVIALHSYEPSHDGDLGFEKGEQLRILEQSGEWWKAQSLTTGQEGFIPFNFVAKANSLEPEPWFFKNLSRKDAERQLLAPGNTHGSFLIRESESTAGSFSLSVRDFDQNQGEVVKHYKIRNLDNGGFYISPRITFPGLHELVRHYTNASDGLCTRLSRPCQTQKPQKPWWEDEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTATEGQYQPQP
  
Inhibitor
Name:
BDBM50077201
Synonyms:
(S)-4-{(S)-2-Acetylamino-3-[4-(carboxy-hydroxy-methyl)-phenyl]-propionylamino}-4-(4-methoxy-benzylcarbamoyl)-butyric acid | CHEMBL48498
Type:
Small organic molecule
Emp. Form.:
C26H31N3O9
Mol. Mass.:
529.539
SMILES:
COc1ccc(CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](Cc2ccc(cc2)C(O)C(O)=O)NC(C)=O)cc1
Structure:
Search PDB for entries with ligand similarity: